BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 18582596)

  • 1. A role for lysosomes in the turnover of human iron regulatory protein 2.
    Dycke C; Charbonnier P; Pantopoulos K; Moulis JM
    Int J Biochem Cell Biol; 2008; 40(12):2826-32. PubMed ID: 18582596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human iron regulatory protein 2 is easily cleaved in its specific domain: consequences for the haem binding properties of the protein.
    Dycke C; Bougault C; Gaillard J; Andrieu JP; Pantopoulos K; Moulis JM
    Biochem J; 2007 Dec; 408(3):429-39. PubMed ID: 17760563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and biochemical characterization of iron regulatory proteins 1 and 2 in Saccharomyces cerevisiae.
    Phillips JD; Guo B; Yu Y; Brown FM; Leibold EA
    Biochemistry; 1996 Dec; 35(49):15704-14. PubMed ID: 8961933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide inhibits the degradation of IRP2.
    Wang J; Chen G; Pantopoulos K
    Mol Cell Biol; 2005 Feb; 25(4):1347-53. PubMed ID: 15684386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron regulatory proteins 1 and 2 in human monocytes, macrophages and duodenum: expression and regulation in hereditary hemochromatosis and iron deficiency.
    Recalcati S; Alberghini A; Campanella A; Gianelli U; De Camilli E; Conte D; Cairo G
    Haematologica; 2006 Mar; 91(3):303-10. PubMed ID: 16503547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron-dependent degradation of IRP2 requires its C-terminal region and IRP structural integrity.
    Wang J; Chen G; Lee J; Pantopoulos K
    BMC Mol Biol; 2008 Jan; 9():15. PubMed ID: 18226225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights on regulation and function of the iron regulatory protein 1 (IRP1).
    Wang J; Chen G; Filebeen C; Pantopoulos K
    Hemoglobin; 2008; 32(1-2):109-15. PubMed ID: 18274988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox control of iron regulatory protein 2 stability.
    Hausmann A; Lee J; Pantopoulos K
    FEBS Lett; 2011 Feb; 585(4):687-92. PubMed ID: 21281640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changed iron regulation in scrapie-infected neuroblastoma cells.
    Fernaeus S; Hälldin J; Bedecs K; Land T
    Brain Res Mol Brain Res; 2005 Feb; 133(2):266-73. PubMed ID: 15710243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete loss of iron regulatory proteins 1 and 2 prevents viability of murine zygotes beyond the blastocyst stage of embryonic development.
    Smith SR; Ghosh MC; Ollivierre-Wilson H; Hang Tong W; Rouault TA
    Blood Cells Mol Dis; 2006; 36(2):283-7. PubMed ID: 16480904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxalomalate, a competitive inhibitor of aconitase, modulates the RNA-binding activity of iron-regulatory proteins.
    Festa M; Colonna A; Pietropaolo C; Ruffo A
    Biochem J; 2000 Jun; 348 Pt 2(Pt 2):315-20. PubMed ID: 10816424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-association and ligand-induced conformational changes of iron regulatory proteins 1 and 2.
    Yikilmaz E; Rouault TA; Schuck P
    Biochemistry; 2005 Jun; 44(23):8470-8. PubMed ID: 15938636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammalian tissue oxygen levels modulate iron-regulatory protein activities in vivo.
    Meyron-Holtz EG; Ghosh MC; Rouault TA
    Science; 2004 Dec; 306(5704):2087-90. PubMed ID: 15604406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron regulates the intracellular degradation of iron regulatory protein 2 by the proteasome.
    Guo B; Phillips JD; Yu Y; Leibold EA
    J Biol Chem; 1995 Sep; 270(37):21645-51. PubMed ID: 7665579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of heme regulatory motif in heme-mediated ubiquitination and degradation of IRP2.
    Ishikawa H; Kato M; Hori H; Ishimori K; Kirisako T; Tokunaga F; Iwai K
    Mol Cell; 2005 Jul; 19(2):171-81. PubMed ID: 16039587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron regulatory protein 2 turnover through a nonproteasomal pathway.
    Chang AH; Jeong J; Levine RL
    J Biol Chem; 2011 Jul; 286(27):23698-707. PubMed ID: 21558272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium nitroprusside promotes IRP2 degradation via an increase in intracellular iron and in the absence of S nitrosylation at C178.
    Wang J; Fillebeen C; Chen G; Andriopoulos B; Pantopoulos K
    Mol Cell Biol; 2006 Mar; 26(5):1948-54. PubMed ID: 16479012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental changes in the expression of iron regulatory proteins and iron transport proteins in the perinatal rat brain.
    Siddappa AJ; Rao RB; Wobken JD; Leibold EA; Connor JR; Georgieff MK
    J Neurosci Res; 2002 Jun; 68(6):761-75. PubMed ID: 12111837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of hypolipidemic drug clofibrate in altering iron regulatory proteins IRP1 and IRP2 activities and hepatic iron metabolism in rats fed a low-iron diet.
    Huang HL; Shaw NS
    Toxicol Appl Pharmacol; 2002 Apr; 180(2):118-28. PubMed ID: 11969379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tempol-mediated activation of latent iron regulatory protein activity prevents symptoms of neurodegenerative disease in IRP2 knockout mice.
    Ghosh MC; Tong WH; Zhang D; Ollivierre-Wilson H; Singh A; Krishna MC; Mitchell JB; Rouault TA
    Proc Natl Acad Sci U S A; 2008 Aug; 105(33):12028-33. PubMed ID: 18685102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.